Meet Yaral Pharma a Dynamic Newcomer to the US Generic Industry | Yaral Pharma

YARAL Pharma, Inc., which launched in 2022, is the U.S. generics subsidiary of IBSA, a long-standing, fully integrated, multinational pharmaceutical company headquartered in Lugano, Switzerland. Yaral is committed to providing high-quality products across a range of therapeutic areas, ensuring continuity of supply, and offering affordable authorized generics and complex generic medicines.    

Order here: 

https://yaralpharma.com/diclofenac/